| |
| |
|
| Insider
Information: |
Rice Derica W |
| Relationship: |
|
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
117,836 |
|
|
Indirect Shares
|
380,351 |
|
|
| Direct
Value |
$35,663,201 |
|
|
|
Indirect Value
|
$304,471,093 |
|
|
| Total
Shares |
498,187 |
|
|
| Total
Value |
$340,134,295 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP-Global Services an... |
2017-02-03 |
38,292 |
2017-02-03 |
374,958 |
Premium* |
|
|
Target Corp |
TGT |
Director |
2024-03-13 |
8,159 |
2007-09-12 |
0 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
EVP & President, CVS C... |
2020-02-28 |
50,922 |
2019-05-31 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
|
0 |
2020-09-01 |
1,200 |
Premium* |
|
|
The Carlyle Group Inc |
CG |
|
2024-05-01 |
20,463 |
2024-05-01 |
4,193 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-01-26 |
4 |
A |
$81.96 |
$3,022,275 |
D/D |
36,875 |
36,875 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-03 |
4 |
AS |
$76.81 |
$302,401 |
D/D |
(3,937) |
36,931 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-03 |
4 |
AS |
$77.47 |
$301,513 |
D/D |
(3,892) |
38,292 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2014-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,392 |
38,870 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-01-27 |
4 |
A |
$75.38 |
$2,938,312 |
D/D |
38,980 |
38,980 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2011-02-15 |
4 |
AS |
$34.55 |
$429,837 |
D/D |
(12,441) |
39,461 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-01 |
4 |
AS |
$78.36 |
$512,945 |
D/D |
(6,546) |
40,868 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2010-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,999 |
40,999 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-02 |
4 |
AS |
$76.97 |
$559,572 |
D/D |
(7,270) |
42,184 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2015-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,708 |
43,778 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-01 |
4 |
D |
$79.10 |
$723,449 |
D/D |
(9,146) |
47,414 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2014-09-04 |
4 |
OE |
$55.65 |
$1,284,235 |
D/D |
23,077 |
48,077 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2016-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,007 |
49,053 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$692,423 |
D/D |
(8,989) |
49,454 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2011-02-01 |
4 |
D |
$34.77 |
$1,079,261 |
D/D |
(31,040) |
51,902 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2013-02-05 |
4 |
AS |
$54.21 |
$1,607,110 |
D/D |
(29,646) |
52,605 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2013-01-25 |
4 |
A |
$53.21 |
$2,865,092 |
D/D |
53,845 |
53,845 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2009-03-03 |
5 |
GA |
$0.00 |
$0 |
I/I |
21,305 |
54,130 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2017-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,055 |
54,703 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2015-02-04 |
4 |
AS |
$70.00 |
$372,120 |
D/D |
(5,316) |
55,061 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2015-01-28 |
4 |
A |
$70.97 |
$3,985,533 |
D/D |
56,158 |
56,158 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2012-02-02 |
4 |
AS |
$39.61 |
$150,518 |
D/D |
(3,800) |
56,196 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,685 |
56,560 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,463 |
58,443 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2014-02-03 |
4 |
AS |
$0.00 |
$0 |
D/D |
(16,562) |
58,990 |
0 |
- |
|
107 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
